Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 2, 2008 - Issue
Submit an article Journal homepage
26
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A safety-modified SV40 Tag developed for human cancer immunotherapy

Stephanie S Tseng-Rogenski1 Department of Urology, School of Medicine, University of Michigan, Ann Arbor, MI, USA
,
Mohamed S Arredouani2 Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
,
June F Escara-Wilke1 Department of Urology, School of Medicine, University of Michigan, Ann Arbor, MI, USA
,
Yilin C Neeley1 Department of Urology, School of Medicine, University of Michigan, Ann Arbor, MI, USA
,
Michael J Imperiale3 Department of Microbiology and Immunology, School of Medicine, University of Michigan, Ann Arbor, MI, USA
&
Martin G Sanda1 Department of Urology, School of Medicine, University of Michigan, Ann Arbor, MI, USA;2 Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
Pages 17-24 | Published online: 28 Sep 2022

References

  • AhujaDSaenz-RoblesMTPipasJM2005SV40 large T antigen targets multiple cellular pathways to elicit cellular transformationOncogene2477294516299533
  • BenderMAChristensenJBrockmanWW1983Characterization of a T-antigen-negative revertant isolated from a mouse cell line which undergoes rearrangement of integrated simian virus 40 DNAJ Virol47115246306268
  • BrooksSEAdachiMHoffmanLM1988Induction of lymphomas and fibrosarcomas in nude mice after implantation of simian virus 40-transformed human meningiomaLab Invest58518232835549
  • ButelJSLednickyJA1999Cell and molecular biology of simian virus 40: implications for human infections and diseaseJ Natl Cancer Inst91119349923853
  • CarboneMRizzoPPassHI1997Simian virus 40, poliovaccines and human tumors: a review of recent developmentsOncogene151877889365233
  • DeppertWHaugMSteinmayerT1987Modulation of p53 protein expression during cellular transformation with simian virus 40Mol Cell Biol74453632830494
  • GarceaRLImperialeMJ2003Simian virus 40 infection of humansJ Virol7750394512692206
  • InabaKInabaMRomaniN1992Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorJ Exp Med17616937021460426
  • JasaniBCristaudoAEmriSA2001Association of SV40 with human tumoursSemin Cancer Biol11496111243899
  • KleinGPowersACroceC2002Association of SV40 with human tumorsOncogene211141911850833
  • KohliMJorgensenTJ1999The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responsesBiochem Biophys Res Commun2571687610092528
  • MylinLMBonneauRHLippolisJD1995Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigenJ Virol696665777474076
  • PhelpsALGatesAJHillierM2007Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccineVaccine25344216950548
  • ReddelRRSalghettiSEWilleyJC1993Development of tumorigenicity in simian virus 40-immortalized human bronchial epithelial cell linesCancer Res53985918094998
  • SchellTDLippolisJDTevethiaSS2001Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigenCancer Res61873911221873
  • ShahKV2000Does SV40 infection contribute to the development of human cancers?Rev Med Virol10314310654003
  • ShenYNemunaitisJ2005Fighting cancer with vaccinia virus: teaching new tricks to an old dogMol Ther111809515668130
  • SongGYGibsonGHaqW2007An MVA vaccine overcomes tolerance to human p53 in mice and humansCancer Immunol Immunother56119320517219151
  • TanakaYTevethiaMJKalderonD1988Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigenVirology162427362448953
  • VilchezRAButelJS2003aSimian virus 40 and its association with human lymphomasCurr Oncol Rep5372912895387
  • VilchezRAButelJS2003bSimian virus 40 infection in lymphoproliferative disordersLancet3611565 author reply 1565–612737902
  • XieYCHwangCOverwijkW1999Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigenJ Natl Cancer Inst91169759923859

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.